Tuesday, October 31, 2017

The Innovation Health Care Really Needs: Help People Manage Their Own Health

By Clayton M. Christensen, Andrew Waldeck, And Rebecca Fogg
October 30, 2017

Finally, health care, which has been largely immune to the forces of disruptive innovation, is beginning to change. Seeing the potential to improve health with simple primary-care strategies, some of the biggest incumbent players are inviting new entrants focused on empowering consumers into their highly regulated ecosystems, bringing down costs.
This shift is long overdue. Whereas new technologies, competitors, and business models have made products and services more affordable and accessible in media, finance, retail, and other sectors, U.S. health care keeps getting costlier. It is now by far the world’s most expensive system per capita, about twice that of the UK, Canada, and Australia, with chronic conditions such as diabetes and heart disease now accounting for more than 80% of total spending.
These astronomical costs are largely due to the way competition works in American health care. Employers and insurance companies — not end consumers — call the shots on what kind of care they will pay for. Large hospitals and physician practices, in turn, compete as if they’re in an arms race to attract payers, adding advanced diagnostic gear or new surgical wings to differentiate, driving up costs.
In most industries, disruption comes from startups. Yet almost all health care innovation funded since 2000 has been for sustaining the industry’s business model rather than disrupting it. Our analysis of Pitchbook Data shows that more than $200 billion has been poured into health care venture capital, mostly in biotech, pharma, and devices where advances typically make health care more sophisticated — and expensive. Less than 1% of those investments have focused on helping consumers to play a more active role in managing their own health, an area ripe for disruptive approaches.
The Whole-Person Approach
One big incumbent that has become more receptive to disruptive innovation is the insurance giant Humana. It has partnered with Boston-based startup Iora Health. Created by physician-entrepreneur Rushika Fernandopulle, Iora has advanced a disruptive primary-care model that uses relatively inexpensive, nonphysician health coaches to identify patients’ unhealthy habits and life styles and guide them toward better choices, before health problems arise or become serious. Since its founding in 2010, Iora has attracted more than $123 million in funding and now operates 37 practices serving 40,000 patients in 11 states. Iora trains health coaches to become the consumer’s advocate, acting as the quarterback of an extended care team that includes a physician. When visiting an Iora clinic, the patient meets with the coach to establish a health agenda before seeing the doctor. After the patient sees the physician, the health coach and patient debrief to ensure the patient can confidently pursue the agreed-upon health goals — for example, by adopting new health habits. The coach then serves as the patient’s connection with the Iora team, and creates accountability.
Another feature of the Iora model is the morning huddle, when the entire care team invests an hour discussing the health status of the clinic’s population. Because Iora assumes full financial risk for its patients — it is paid a set fee per patient for a given period — the huddle prioritizes those who require the most attention and directs care around their needs.
To that end, Iora has developed a “worry score” methodology, which rates each patient on a 1-to-4 scale according to their health status and needs. Patients scoring a 4 require a specific action, such as immediate outreach from a health coach. If the patient’s outlook turns for the better, their worry score is lowered, a development celebrated by the team.
The Iora model has produced dramatic results in the management of chronic conditions. For example, an unpublished Iora study found that inpatient hospital admissions among a cohort of 1,176 Iora Medicare enrollees over an 18-month period decreased by 50%, emergency department visits decreased by 20%, and the total medical spend declined by 12% — this despite the cohort being sicker than average Medicare patients.
Other new entrants (Oak StreetOmadaDocentChenMedWellMedMosaic, and Aledade, among them) are also successfully implementing Iora’s care-team and fee-for-value reimbursement model. What make the model disruptive — and able to get a foothold among mammoth incumbent provider organizations — is the combination of delivery and payment schemes (capitation is the predominant model); either alone would be unlikely to succeed.
Encouraging Disruption
Payers are getting onboard. A range of recent pilot programs modeled on Iora’s — by Aetna, CareMore, Dignity Health, Humana, Kaiser Permanente, and the Medicare Advantage program — are using coaches and home visits to substantially improve health and lower costs. One study found that providers participating in Medicare’s Independence at Home Demonstration saved $1,010 per beneficiary on average in the second year of the program, primarily by reducing hospital use.
Another care-team-based pilot, the Diabetes Prevention Program, reduced patients’ risk of developing the disease and saved Medicare an estimated $2,650 per beneficiary over a 15-month period by helping patients lose an average 5% of their body weight through changes in diet and exercise. The program is delivered through primary care groups, hospitals, YMCAs, and telehealth networks, and patients are supported by weekly, hourlong “maintenance sessions” with coaches.
While this care model has proved powerful at a small scale, to have significant impact on costs and outcomes nationally it must serve millions more consumers. To achieve that scale, we recommend the following strategies:
For care providers: Embrace the business model of extended care teams that include health coaches. We recommend starting with pilot programs under which hospitals and clinics take on financial risk for patients’ health. This way, care teams are incentivized to help patients stay healthy.
For payers and insurers: Private-public partnerships like Medicare Advantage (under which for-profit insurers administer plans paid for by the government) have become successful marketplaces that allow disruptive models. We recommend extending programs modeled on pilots like Independence at Home and the Diabetes Prevention Program across privately-funded insurance markets.
For legislators: Work to enable new models of care that lower costs by incenting individuals, payers, and providers to improve wellness, rather than treat disease after it manifests. This requires fostering a robust individual insurance market in which payers reward providers for helping patients stay healthy.
https://hbr.org/2017/10/the-innovation-health-care-really-needs-help-people-manage-their-own-health?itx[idio]=8812325&ito=792&itq=20925643-efdb-4ac1-b213-def699bedb1c

August 2017 monthly report on state Medicaid and Children's Health Insurance Program (CHIP) eligibility and enrollment data.

Medicaid.gov
Today the Centers for Medicare & Medicaid Services (CMS) released the August 2017 monthly report on state Medicaid and Children's Health Insurance Program (CHIP) eligibility and enrollment data.
The full report is available on Medicaid.gov at https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html

90,107 ...

... managed Medicaid and SCHIP lives will be up for grabs when UnitedHealthcare discontinues its Delaware Medicaid contract on Dec. 31, 2017. Those members will likely be absorbed by Highmark Health, which has served Delaware Medicaid since 2015, and AmeriHealth Caritas, which won a Medicaid contract from the state in October.

Quote of the Day

"I go into these meetings and [Medicare Advantage plan executives are] debating whether it would help to have a dollar advantage on a copay. They need to focus on the big picture."


— Cary Badger, principal at HealthScape Advisors, LLC, tells Health Plan Week that Medicare Advantage plans should focus on consistency in plan design instead of getting fixated on products and prices.

The updated Affordable Care Act Federal Upper Limits (FUL)

Medicaid.gov
The updated Affordable Care Act Federal Upper Limits (FUL) calculated in accordance with the Medicaid Covered Outpatient Drug final rule with comment are now available on the Medicaid.gov website at https://www.medicaid.gov/medicaid/prescription-drugs/pharmacy-pricing/index.html. States will have up to 30 days from the November 1, 2017 effective date to implement these updated FULs.  
For further information on the FUL program, please see the Federal Upper Limits page at https://www.medicaid.gov/medicaid/prescription-drugs/federal-upper-limits/index.html.

Is that Phone Call From Us?

It’s the morning of a busy day at home and you get a call from an unknown number. You answer only to find yourself on the receiving end of a threatening message saying your Social Security benefits will stop immediately unless you provide your personal information. It happens every day to thousands of Americans.  And it’s not Social Security calling.
Scammers have many ways to lure their victims into providing information and then stealing their identities. Sometimes they call under a guise of helping you complete a disability application. Protecting your information is an important part of Social Security’s mission to secure today and tomorrow. Any request from our agency will come to you as a written notice first. If you do receive a call from one of our representatives, they will provide you with a telephone number and extension.
The Acting Inspector General for Social Security, Gale Stallworth Stone, urges everyone to stay vigilant of impersonation schemes and to not be afraid to hang up.
You must always remember that you’re in control. Also remember that Social Security will never do any of the following:
  • Call you to demand an immediate payment;
  • Demand that you pay a debt without the ability to appeal the amount you owe;
  • Require a specific means of payment, such as requiring you to pay with a prepaid debit card;
  • Ask you for your personal information or credit or debit card numbers over the phone; or
  • Threaten you with arrest or deportation.
If you receive one of these scam calls or emails, do not provide them with any information. You should:
  • Hang up immediately;
  • For Social Security impersonations, contact Social Security’s Office of Inspector General at https://oig.ssa.gov/report.
If you receive a notice from Social Security, please use the telephone numbers provided in the notice sent to you. You can also call 1-800-772-1213 or visit socialsecurity.gov for how to contact Social Security. Remember that scammers try to stay a step ahead of the curve. You can do the same by protecting your information.
https://blog.socialsecurity.gov/is-that-phone-call-from-us/

Monday, October 30, 2017

ANALYSIS: ACA Marketplace Premiums Rise Substantially in 2018, But Many Will Pay Less for Coverage

KFF
Just Released
ANALYSIS: ACA Marketplace Premiums Rise Substantially in 2018, But Many Will Pay Less for Coverage

County-Level Maps Chart ACA Marketplace Premium Changes for Gold, Silver, Bronze Plans

Premiums will rise substantially in 2018 Affordable Care Act marketplace plans for states using HealthCare.gov, but in many cases, people receiving premium tax credits will pay less than they did in 2017, a new Kaiser Family Foundation analysis finds.
The new analysis includes county-level interactive maps charting premium changes of lowest-cost gold, silver, and bronze plans for consumers with and without premium tax credits in the 2018 HealthCare.gov marketplaces.
For people not eligible for tax credits that defray the cost of premiums, the weighted national average change for the three types of plans in HealthCare.gov marketplaces was 17 percent for lowest-cost bronze plans, 35 percent for lowest-cost silver plans, and 19 percent for lowest-cost gold plans, according to the analysis.
However, in many cases, lower-income consumers receiving premium tax credits will pay less for premiums in 2018 than in 2017, the analysis finds, because their tax credits will rise dollar-for-dollar with benchmark silver premiums. Premiums for silver plans increased much more than those for bronze or gold plans in 2018 because in many states insurers loaded the cost from the termination of the cost-sharing reduction payments entirely on the silver tier.
premium map_October2017.png
The change for the average premium for a 40-year-old person making up to $40,000 who is eligible for premium tax credits ranges from a 75 percent decrease to no change for the lowest-cost gold, silver, and bronze plans, the analysis finds.
The new maps chart premium changes for a 40-year-old individual paying the full premium and for a 40-year-old individual eligible for tax credits, with an income of $25,000, $30,000, $35,000 and $40,000.
The maps show:
  • Premium changes of lowest-cost gold, silver, and bronze plans in each county in states using HealthCare.gov.
  • Counties where the premium tax credit would cover the full premium for the lowest-cost bronze plan in 2018.
  • Counties where the premium for the lowest-cost gold plan is less than or comparable to the unsubsidized premium for the lowest-cost silver plan.
The analysis finds that for a 40-year-old person eligible for a tax credit, the tax credit would cover the full premium of the lowest-cost bronze plan in between 99 and 1,540 counties, depending on the person’s income.
Read the Issue Brief

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.

Flurry Of Federal And State Probes Target Insulin Drugmakers And Pharma Middlemen

By Sarah Jane Tribble October 30, 2017
With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry’s financial middlemen, seeking answers about their business relationships and the soaring price of diabetes drugs.
Attorneys general in Washington, Minnesota and New Mexico issued civil investigative demands this year and are sharing information with Florida and California, according to various corporate financial filings.
Insulin makers Eli Lilly, Novo Nordisk, Sanofi and top pharmacy benefit manager CVS Health are targets in the state investigations. Several of the financial filings note that the state and federal prosecutors want information regarding specific insulins for specific dates in relation to “trade practices.”
They appear to be looking into potentially anti-competitive business dealings that critics have leveled at this more than $20 billion niche market of the pharmaceutical industry, according to analysts and court filings reviewed by Kaiser Health News. These include whether drugmakers and middlemen in the supply chain have allowed prices to escalate in order to increase their profits.
At the same time, prominent class-action lawyers are bringing suits on behalf of patients. Steve Berman, an attorney best known for winning a multibillion-dollar settlement from the tobacco industry, alleged collusion and said it was time to break up the “insulin racket.”
The price of insulin — a lifesaving drug — has reached record highs as Eli Lilly, Novo Nordisk and Sanofi raised prices more than 240 percent over the past decade to often over $300 a vial today, with price rises frequently in lockstep, according to information technology firm Connecture.
Those prices take a toll on patients like 21-year-old Hunter Sego, who needs about four vials a month for his Type 1 diabetes. When he went to the pharmacy last year, the drug was no longer on a preferred tier and the price had risen to $487 a vial, compared with about $200 from a few years ago. Insurance companies often take drugs off a preferred list in response to pharmaceutical price rises to discourage overuse, a business strategy that leaves patients stuck in the middle.
“I was absolutely floored,” Sego said.
The DePauw University junior began skipping doses, knowing that his parents were paying cash until they met their health plan’s high deductible. Sego lost weight and felt lethargic, and his grades suffered. Sego’s college football coach finally called his mother to ask what was going on.
“I have to watch him like a hawk because I know he is trying to save money,” said his mother, Kathy Sego.
Last year, before the states took action, the U.S. Attorney’s Office for the Southern District of New York, one of the nation’s most powerful federal prosecutors, issued civil investigative demands to Eli Lilly, Novo Nordisk, Sanofi and Express Scriptsaccording to financial filings.
“There is enough concern about competition in the drug industry to have galvanized forces at the state and federal level to create specific pictures of abuse,” said Diana Moss, president of the American Antitrust Institute after hearing of the investigative demands.
Attorneys general use the legally binding demands to collect evidence, such as documents and emails, and testimony to help “piece together any number of stories about potential competitive harm,” Moss said.
Insulin prices have risen at regular intervals for years, Connecture’s research shows, but the trend has become more pronounced in the past few yearsFor example, in the final months of 2007, Sanofi’s Lantus cost $88.20 per vial and Novo Nordisk’s Levemir $90.30 a vial. Today, after increasing in tandem over the years, Lantus costs $307.20 per vial and Levemir runs $322.80 for the same amount, based on average wholesale prices.
The increases “don’t all happen on the same exact day, but they happen pretty close to each other on the calendar,” said Jim Yocum, senior vice president of federal contracts with Connecture. “I don’t know of any other industry where such regular price increases have been the norm.”
The United States is one of the few developed countries without regulations on prescription drug pricing. So, one of the few tools available for the government to curb price increases is to show fraudulent or anti-competitive practices.
Late last year, Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) asked the Department of Justice and the Federal Trade Commission to investigate, noting “the potential coordination by these drug makers may not simply be a case of ‘shadow pricing,’ but may indicate possible collusion.”
Spokespeople for Eli Lilly, Novo Nordisk and Sanofi said in separate statements that each company sets prices independently. Novo Nordisk’s Ken Inchausti added: “We monitor market dynamics and our competitors’ pricing through public and subscription databases that track list prices.”
Each of the pharmaceutical companies said it is committed to ensuring patients have access to medicine. Novo Nordisk, which makes Novolog and Levemir, also pledged to limit price increases. Eli Lilly has announced a discounted insulin program.
State and federal prosecutors often begin investigations because of consumer and whistleblower complaints, several civil and antitrust attorneys said, and gripes about rising insulin prices have been roiling the online diabetes community for the past few years.
Indeed, James Tierney, former attorney general of Maine and a lecturer at Harvard Law School, said the civil investigative demands are not uncommon and the companies “may be totally innocent.”
It’s difficult to know exactly what the state and federal prosecutors are looking for, though, Tierney said. The investigations are often sealed from the public, revealed primarily when public companies acknowledge receiving them in their financial filings.
Nearly all of the federal and state officials declined to confirm or deny the investigations, except Washington and New Mexico officials, who confirmed the existence of the civil investigative demands.
Still, clues about the insulin investigations can be pieced together from corporate filings. They focus on issues like pricing and business relationships. Several ask for information about specific insulins regarding certain years.

In January — at about the same time states began filing civil demands — the first of a handful of potential class-action lawsuits that were national in scope were filed.
A U.S. district judge combined Berman’s suit and several other national cases last month, adding the pharmacy benefit managers, or PBMs (Express Scripts, CVS and UnitedHealth Group with its division OptumRx) as defendants.
Berman and the other attorneys declined interview requests. But attorneys at Keller Rohrback, one of the firms whose case was rolled into Berman’s, explained the reason for adding the PBMs in a May letter to the court: “The PBM defendants play a central role in the scheme — selling formulary access in exchange for ‘rebates’ or other payments” from the manufacturers.
Rebates, or negotiated discounts, occur when a manufacturer sets a list price and then agrees to pass money back to the PBMs in return for something, generally a spot on the formulary that determines which drugs can be purchased.
The PBMs say their negotiations ensure drugs are affordable, and two of them pointed fingers back at the drugmakers.
Express Scripts spokesman Brian Henry declined to comment on the investigations or lawsuit but stated in an email that “if prices have gone up in lockstep, that is because they have been priced by the drug makers in lockstep.” UnitedHealth did not respond to questions. And CVS Health called the lawsuit without merit.
CVS spokesman Michael DeAngelis said in an email: “Pharmaceutical companies alone are responsible for the prices they set in the marketplace for the products they manufacture. Nothing in our agreements prevents drug manufacturers from lowering the prices of their insulin products and we would welcome such an action.”
Such lawsuits generally take years to resolve. In the meantime, the suits and the investigations may provide answers to the demands of lawmakers like Sen. Amy Klobuchar (D-Minn.), who sent a letter to drugmakers in July asking for an explanation for the “extreme price increases.”
KHN’s coverage of prescription drug development, costs and pricing is supported in part by the Laura and John Arnold Foundation.

Why giant deal for insurer could mark end of an era

by Bloomberg 30 Oct 2017

If Aetna Inc. is eventually swallowed by CVS Health Corp., an important part of the health-care business will be changed -- perhaps for good.

For years, pharmacy benefits were largely carved out from the rest of a medical coverage plan. But increasingly the two services are being combined, a move that in theory will make it easier to verify whether expensive drugs are worth the cost. A merger of the third-biggest health insurer with the largest US drugstore chain, which also operates a pharmacy-benefit management company, could speed the process.

“You are hearing the warning for the end of the road for the classic standalone” pharmacy-benefit business, said Pratap Khedkar, managing principal at consulting firm ZS Associates.

Drugmakers are producing more pricey treatments for cancer and rare diseases. Combining drug and medical benefits in the same place is “the only way” payers will figure out whether such expensive new drugs are actually making people better and saving money by keeping them out of the hospital, he said.

A merger of CVS and Aetna would create a health-care behemoth and put huge pressure on standalone players such as Express Scripts Holding Co. and Walgreens Boots Alliance Inc. Express Scripts would become the last major standalone pharmacy-benefit manager not allied with a major insurer.

All Channels

CVS and Aetna have held discussions about a potential deal, according to people familiar with the matter who asked not to be identified as the details aren’t public. A newly combined company would “own the entire chain, from prescribing and filling prescriptions to the health plans that pay for them,” said Michael Rea, of Rx Savings Solutions, which has an app that helps patients find lower cost drugs.

Under a combined roof, the insurance arm of CVS-Aetna could help keep costs down by routing patients needing basic urgent care to CVS-owned walk-in clinics and keeping them out of expensive hospital emergency rooms, analyst Ann Hynes of Mizuho Securities said in a note to clients. The company would also become a formidable competitor to UnitedHealth Group Inc., the biggest health insurer and owner of its own PBM unit, OptumRx.

But even with the new clout, a merger isn’t likely to be derailed by federal antitrust authorities, said John Briggs, an antitrust attorney at Axinn Veltrop & Harkrider in Washington.

CVS and Aetna declined to comment.

Walgreens, the No. 2 drugstore operator, could also feel the pressure. A CVS-Aetna marriage could cause the drugstore chain to look for its own acquisition targets, with Express Scripts being the most likely, Charles Rhyee, an analyst at Cowen & Co., wrote in a note to clients Friday.

And then there’s Amazon.com Inc., which recently gained drug-wholesaler licenses in 14 states. The looming threat of the e-commerce behemoth entering the mail-order pharmacy business and pushing down profit margins for drug distributors, benefit managers and retail pharmacies intensifies the pressure on standalone players.

For CVS, the move is “a natural defense against the potential threat of Amazon entering the retail pharmacy market,” Rhyee said.
Another possibility is that Amazon could buy Express Scripts. That would give the internet retailer an instant and large foothold in both the PBM industry and the mail-order pharmacy business.

‘Strong’ Model

Health insurer Anthem Inc., Express Scripts’ biggest current client, announced earlier this month that it would leave Express Scripts when its contract ends at the end of 2019 to form its own PBM unit. And Prime Therapeutics, another major player, manages drug benefits for nonprofit Blue Cross and Blue Shield plans in numerous states.

“Our model is strong and thriving,” said Jennifer Luddy, a spokeswoman for Express Scripts. “We believe in the value that we provide to our customers as an independent PBM.”

On an earnings call this week, Express Scripts Chief Executive Officer Tim Wentworth said he was open to a deal with Amazon to help serve cash-paying patients.

Walgreens declined to comment.

In terms of the CVS-Aetna deal, antitrust authorities will look closely at the competition between the companies in selling Medicare Part D plans for the elderly, said Briggs, the attorney.

There could be fight between the Justice Department and the Federal Trade Commission, which share antitrust enforcement, over which agency will investigate the merger, according to Briggs. The Justice Department handles insurer mergers and successfully stopped the combination of Aetna and Humana Inc. this year. The FTC investigates retail pharmacy deals. In September, it cleared Walgreens’ acquisition of 1,900 Rite Aid Corp. stores after Walgreens shrank the size of the deal.

Still, a CVS-Aetna deal would likely win approval because a number of other major players will remain in the Part D market, he said.

“That’s an easy fix,” Briggs said. “The whole deal is not going to crater on account of Part D.”


Diabetics Fear They Can’t Get Life Insurance

October 23, 2017 

BOSTON  – A new survey commissioned by John Hancock found that almost half (47 percent) of people living with diabetes are worried they won’t qualify for a life insurance policy, and another 45 percent assume it’s too expensive. On the contrary, more than 90 percent of all the people with diabetes who sought life insurance from John Hancock in the past 18 months qualified, with 88 percent of them receiving a standard or better rate.
“Our survey confirmed a pervasive belief among many people with diabetes that they either won’t qualify for life insurance or that it isn’t affordable,” said Brooks Tingle, senior vice president and interim head of John Hancock Insurance. “John Hancock is committed to helping all Americans understand that life insurance is both attainable and an important way to protect their families’ future. In fact, a new kind of life insurance allows people with diabetes to pay less for their annual premiums simply by making healthy choices like getting regular check-ups, eating well and staying active.”
According to the survey, people with diabetes recognize the many benefits life insurance can provide—including providing for their family (81%), covering final expenses (68%), and providing peace of mind (50%). Yet almost 40 percent of people with diabetes who don’t have a life insurance policy say they are unlikely to apply for one in the future.
Survey respondents’ hesitation comes from confusion about life insurance, especially for those living with diabetes. Only 32 percent of people with diabetes consider themselves knowledgeable about life insurance. Their top questions include:
- Is life insurance more expensive because I have diabetes? (51%)
- Will I be able to get life insurance with diabetes? (47%)
- Will I need a medical exam in order to get life insurance? (41%)
- Can I afford a life insurance policy? (40%)
A new kind of life insurance
John Hancock life insurance with Vitality rewards policyholders for the choices they make every day to improve their health—exercising regularly, eating well and visiting the doctor—things people with diabetes are already encouraged to do.
Customers can earn valuable rewards, including an Apple Watch for $25 by exercising regularly and $600 in annual savings on healthy food purchases, and can save as much as 15 percent on their annual life insurance premiums.
About 75 percent of people with diabetes say this kind of life insurance that rewards and saves them money for healthy activities is appealing. More than that:
- 65 percent agree it would motivate them to live a healthier life.
- 60 percent agree it would provide them with additional support to help them manage their diabetes.
- 52 percent agree it would help them to afford life insurance.
Over 30 million people in the U.S. are living with diabetes, and another 84 million have prediabetes. Globally, diabetes is considered the single greatest chronic disease threat to health today.
“With advancements in treatments and underwriting, most people living with diabetes can get the important life insurance coverage they need,” said Brooks Tingle. “John Hancock’s long-standing experience in the industry, along with our in-depth medical knowledge, puts us in a unique position to offer life insurance to people living with diabetes, particularly those who are successfully managing their condition. And we find that the vast majority of people living with diabetes are doing just that.”
To learn more about life insurance that rewards you for healthy living, visit JHRewardsLife.com.
https://insurancenewsnet.com/oarticle/diabetics-fear-cant-get-life-insurance#.WfdKPFVuKJA

Big Gains In Latino Coverage Poised To Slip During Chaotic Enrollment Season

By Paula Andalo October 30, 2017
Latinos, who just a year ago were highly sought customers for the Affordable Care Act’s marketplace plans may not get the same hard sell this year.
The Trump administration’s laissez-faire approach toward the upcoming enrollment period for the health law’s insurance marketplaces could reverse advances made in the number of Latinos with coverage, fear navigators and community activists.
Enrollment outreach efforts during the Obama administration targeted Latinos, both because they have a high uninsured rate and because a large proportion of the community is young and fairly healthy, criteria prized by insurers to help balance older, sicker customers, who are more likely to sign up.
Nearly a million people who identify themselves as Latino or Hispanic enrolled in marketplace plans this year, making up a tenth of customers. The uninsured rate among Latinos dropped from 43 percent in 2010 to under 25 percent in 2016. Still, millions are eligible and remain uninsured.
A shorter enrollment season and cutbacks in federal funding for marketing and navigator groups have the potential to allow Latino enrollment to slip, the advocates say.
Enrollment for the 39 states using the federal website begins Nov. 1 and ends Dec. 15, about a month and a half less than in the previous year. Some states running their own exchanges have extended that period into January.
Claudia Maldonado, program director for the Keogh Health Connection in Phoenix, an organization that connects underserved people with health services, said uncertainty is what dominates these days. “We’re getting ready, because we know it’s going to be a difficult open enrollment period.”
The Spanish-language enrollment website, cuidadodesalud.gov, will be operating again this year, federal officials said, but it will face the same scheduled maintenance shutdowns as its Anglo sibling, healthcare.gov.
The Centers for Medicare & Medicaid Services (CMS), which manages the federal online insurance marketplaces, announced last month that the sites would be “closed for maintenance” for half the day on Sundays during the open enrollment period. The states that run their own marketplaces, such as California and New York, will not be affected by the shutdowns.
In Darkness
It’s unfortunate the service disruption of cuidadodesalud.gov will happen on Sundays, said Daniel Bouton, director of health services for the Community Council of Greater Dallas, a nonprofit that helps Latinos sign up for health care. “The day that Hispanic families go to church, where they are all together and where we have been enrolling them in previous years.”
“People want to have the issue of their health coverage resolved,” said Anne Packham, director of the insurance marketplace project at Covering Central Florida, an Orlando-based organization. “And all the announcements about Obamacare frustrate them.”
Enrolling a consumer on the exchanges is not a 10-minute process. A family can purchase a health plan there and also learn if they are eligible for Medicaid or CHIP, the federal-state insurance program for children in low-income families that earn too much to qualify for Medicaid. It can take up to an hour and a half and often requires more than one session with the navigator, who are the certified insurance market experts who have helped enroll millions of Latinos across the country.
Many Hispanics prefer to sign up for coverage in person with a trained navigator, said several people with experience helping consumers.
In an email, CMS said that scheduled website outages would not affect the enrollment flow and that the federal call center where consumers can get help with enrollment questions “will continue to assist callers.”
“It is important to note that the duration of the potential Sunday outages are the maximum amount of time allowed for the maintenance; actual outage times could be shorter,” the email added.
An Alternative Website
The Spanish-language website had a rough start when Obamacare plans launched in 2013, not coming online until two months after the English version. Still, navigators say that cuidadodesalud.gov often serves as a “last resort” for consumers, both Latinos and others, when they have technical problems with the English version.
Resources
Frequently asked questions:
·         In English
·         In Spanish
CMS call center, available 24/7: 1-800-318-2596
“In past registrations, many times when healthcare.gov was down, the Spanish site was not,” said Bouton.
“Navigators are bilingual and generally use the site in English, but when it is not working well, they end the registration process in cuidadodesalud.gov, which often worked better [than healthcare.gov] in previous years,” said Julia Holloway, director of program development and navigator services for Affiliated Service Providers of Indiana, in Indianapolis. Her program has been told by federal officials that it will get 82 percent less money for navigators during the open season this fall.
The lower flow of consumers on cuidadodesalud.gov has made the Spanish version technologically more stable than the English version.
From Nov. 1, 2015, to Jan. 2, 2016, nearly 20 million people used healthcare.gov, compared with 953,708 who navigated cuidadodesalud.gov.
Fear Of Deportations
Edgar Aguilar, program manager with Community Health Initiative, a network of grass-roots organizations in California that assist people signing up for insurance, said even though California does not face some of the same challenges as states using the federal marketplace, enrollment this year will be challenging.
He is in charge of the operation in Kern County, in the Central Valley, which has a high population of Latino farmers.
“We were successful signing up Latinos in the past, there are less than 8 percent of Latinos without insurance in the county, but the confusion about what is happening with Obamacare and the fear of immigration problems make people think twice before renewing a health plan or [signing] up their kids for Medicaid or CHIP”, he said.
Navigators surveyed for this article said they feel more tension this year in the days leading up to the start of enrollment.
Hispanic members of Congress sent a letter to the Department of Health and Human Services in August seeking reassurance that enrollment outreach would continue for Latinos. A spokesperson for the caucus said an HHS representative promised to set up a meeting on the issue, but it never happened.
One hurdle to enrollment is the fear of deportations. Undocumented immigrants do not have the right to buy health insurance through the ACA markets, but there are thousands of families with mixed immigration status, and advocates fear they may be hesitant to buy insurance or apply for subsidies to help pay for coverage.
“Since the new government took office, when raids increased and the legal status of ‘Dreamers’ [young people brought to the U.S. while children] was in jeopardy, people started canceling their appointments with the navigators, and stopped enrolling their children in Medicaid or CHIP,” said Bouton.
However, navigators said they aren’t giving up. “We keep making calls. We have the same goal of registering more people,” said Maldonado. Her organization is operating with a 30 percent lower budget for navigators. In her state, Cover Arizona, a network of nonprofit organizations, continues to organize events, hand out leaflets and make calls to encourage enrollment.
“We had to cut the budget for marketing, but another organization that did not have that cut helps us and distributes our brochures,” said Bouton. More than ever, navigators say, the focus is on teamwork.
“We are passionate about what we do, and we will try to enroll as many people as possible,” said Holloway.